Skip to main content

Research Repository

Advanced Search

Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized Controlled Trial (RELIEF)

Smith, Jaclyn A.; Morice, Alyn H.; Birring, Surinder S.; Parker, Sean M.; Marsden, Paul A.; Holcomb, John R.; Sher, Mandel; Prenner, Bruce M.; Steven, Gary; Carroll, Kevin J.; Lanouette, Sylvain; Garceau, Denis; Harvey, Laurent; Bonuccelli, Catherine M.

Authors

Jaclyn A. Smith

Surinder S. Birring

Sean M. Parker

Paul A. Marsden

John R. Holcomb

Mandel Sher

Bruce M. Prenner

Gary Steven

Kevin J. Carroll

Sylvain Lanouette

Denis Garceau

Laurent Harvey

Catherine M. Bonuccelli



Citation

Smith, J. A., Morice, A. H., Birring, S. S., Parker, S. M., Marsden, P. A., Holcomb, J. R., Sher, M., Prenner, B. M., Steven, G., Carroll, K. J., Lanouette, S., Garceau, D., Harvey, L., & Bonuccelli, C. M. (2025). Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized Controlled Trial (RELIEF). American Journal of Respiratory and Critical Care Medicine, 211(6), 1072-1075. https://doi.org/10.1164/rccm.202501-0093RL

Journal Article Type Letter
Acceptance Date Mar 5, 2025
Online Publication Date Mar 5, 2025
Publication Date Jun 1, 2025
Deposit Date Jun 27, 2025
Publicly Available Date Jun 27, 2025
Journal American Journal of Respiratory and Critical Care Medicine
Print ISSN 1073-449X
Publisher American Thoracic Society
Peer Reviewed Peer Reviewed
Volume 211
Issue 6
Pages 1072-1075
DOI https://doi.org/10.1164/rccm.202501-0093RL
Public URL https://hull-repository.worktribe.com/output/5241693

Files

Published article (580 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0

Copyright Statement
Copyright © 2025 by the American Thoracic Society.
This article is open access and distributed under the terms of the
Creative Commons Attribution 4.0 International License (https://
creativecommons.org/licenses/by/4.0/).




You might also like



Downloadable Citations